Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Loncar China Biopharma ETF (CHNA)

Loncar China Biopharma ETF (CHNA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family Exchange Traded Concepts
  • Assets Under Management 11,796,800
  • Market Capitalization, $K 11,797
  • Shares Outstanding, K 450
  • 60-Month Beta 1.36
  • Price/Earnings ttm 18.16
  • Annual Dividend & Yield 0.04 (0.15%)
  • Most Recent Dividend 0.040 on 12/23/19
  • Management Fee 0.79%
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
24.19 +9.22%
on 12/19/19
26.42 unch
on 01/17/20
+1.99 (+8.12%)
since 12/17/19
3-Month
22.86 +15.55%
on 10/23/19
26.42 unch
on 01/17/20
+3.42 (+14.88%)
since 10/17/19
52-Week
19.66 +34.39%
on 01/25/19
26.42 unch
on 01/17/20
+5.87 (+28.57%)
since 01/17/19

Most Recent Stories

More News
Loncar China BioPharma ETF (CHNA) Celebrates One-Year Anniversary

The Loncar China BioPharma ETF (Nasdaq: CHNA) today celebrates one year of trading on the Nasdaq in the United States. The fund gives investors exposure to 29 companies at the heart of China's biopharmaceutical...

CHNA : 26.42 (+0.80%)
Cancer-Fighting Stocks & ETF: What You Need to Know

Many biotech stocks soared after they presented very promising cancer treatment results at the ASCO conference

BMY : 66.72 (-0.09%)
MRK : 90.97 (-0.23%)
AZN : 51.33 (+1.62%)
CNCR : 23.43 (-0.60%)
CHNA : 26.42 (+0.80%)
NKTR : 22.48 (-5.94%)
IOVA : 23.88 (+0.57%)
Why Cancer-Fighting Stocks & ETFs Are Soaring

The cancer immunotherapy ETF is soaring today as some of its holdings presented very promising results at the ASCO conference. Find out more on the podcast.

LLY : 139.58 (-1.31%)
AZN : 51.33 (+1.62%)
BMY : 66.72 (-0.09%)
MRK : 90.97 (-0.23%)
CNCR : 23.43 (-0.60%)
CELG : 108.24 (+0.10%)
MRTX : 97.05 (-0.39%)
NKTR : 22.48 (-5.94%)
IOVA : 23.88 (+0.57%)
CHNA : 26.42 (+0.80%)
Why These Chinese Sector ETFs Are Crushing S&P 500 in 2019

Policy easing in the Chinese economy, cooling trade tensions with the United States and Beijing's efforts for more urbanization have boosted these sector ETFs in 2019.

CHNA : 26.42 (+0.80%)
CHIS : 22.66 (-0.20%)
CHIR : 19.83 (-0.82%)
CHIH : 19.05 (+1.02%)
Why These Chinese Sector ETFs Are Crushing S&P 500 in 2019

Policy easing in the Chinese economy, cooling trade tensions with the United States and Beijing's efforts for more urbanization have boosted these sector ETFs in 2019.

CHNA : 26.42 (+0.80%)
CHIS : 22.66 (-0.20%)
CHIR : 19.83 (-0.82%)
CHIH : 19.05 (+1.02%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Trade CHNA with:

Fund Summary

The China BioPharma ETF offers exposure to a basket of companies powering China's biopharmaceutical industry. With a long-term goal of steering its economy towards innovation, China aims be a global leader in medicine. CHNA seeks to invest in this opportunity with the convenience of one security that...

See More

Top 10 Holdings

Name % Holdings
CSPC PHARMACEUTICA 5.73%
WUXI APPTEC CO LTD 5.63%
WUXI BIOLOGICS (CA 4.84%
CANSINO BIOLOGICS 4.83%
HANSOH PHARMACEUTI 4.70%
SINO BIOPHARMACEUT 4.69%
LIVZON PHARMACEUTI 4.44%
CHINA MEDICAL SYS 4.24%
SINOPHARM GROUP CO 3.95%
HUTCHISON CHINA MEDITECH LTD SPONSORED ADR 3.72%

See More

Key Turning Points

2nd Resistance Point 26.51
1st Resistance Point 26.47
Last Price 26.42
1st Support Level 26.33
2nd Support Level 26.24

See More

52-Week High 26.42
Last Price 26.42
Fibonacci 61.8% 23.84
Fibonacci 50% 23.04
Fibonacci 38.2% 22.24
52-Week Low 19.66

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar